BJL
ALDX icon

Brighton Jones LLC’s Aldeyra Therapeutics ALDX Stock Holding History

Brighton Jones LLC’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.5K Buy
+22,199
New +$97.3K ﹤0.01% 1174
2025
Q4 		– Sell
-19,945
Closed -$104K – 86
2025
Q3 		$104K Buy
19,945
+2,046
+11% +$10.7K ﹤0.01% 990
2025
Q2 		$68.6K Buy
+17,899
New +$46.3K ﹤0.01% 901

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Brighton Jones LLC's ALDX Position: Q1 2026 in Review

Brighton Jones LLC opened a new position in Aldeyra Therapeutics (ALDX) in Q1 2026: 22,199 shares worth $37.5K. The stake represents ﹤0.01% of the portfolio and ranks #1174 among its holdings. This is a return to the name: Brighton Jones LLC previously reported a position in ALDX as recently as Q3 2025.

Brighton Jones LLC first reported a position in ALDX in Q2 2025 and has held it in 3 quarters since. The position peaked at $104K in Q3 2025. 128 funds tracked by Wall St. Rank hold ALDX as of Q1 2026.

  • Brighton Jones LLC held 22,199 shares of Aldeyra Therapeutics worth $37.5K as of Q1 2026.
  • Aldeyra Therapeutics was a new Brighton Jones LLC position in Q1 2026.
  • Aldeyra Therapeutics made up ﹤0.01% of Brighton Jones LLC's portfolio in Q1 2026, its #1174 holding.
  • Brighton Jones LLC first reported a position in Aldeyra Therapeutics in Q2 2025 and has held it in 3 quarters since.
  • Brighton Jones LLC's Aldeyra Therapeutics position peaked at $104K in Q3 2025.
  • 128 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2026.

Based on Brighton Jones LLC's 13F filing for Q1 2026, filed 28 Apr 2026.